← FDA DRUG APPROVALS

FDA ANDA · ANDA212465

MUPIROCIN

Sponsor: PADAGIS ISRAEL

APPLICATION
ANDA212465
TYPE
ANDA
ORIGINAL APPROVAL
2022-08-03
LATEST ACTION
2022-08-03
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

MUPIROCINDiscontinued
MUPIROCIN CALCIUM EQ 2% BASE · CREAM · TOPICAL

Approval history

2022-08-03UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →